Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the first-to-market launch of Naproxen and Esomeprazole Magnesium Delayed-Release Tablets, a therapeutic equivalent generic version of Vimovo ® (Naproxen and Esomeprazole Magnesium) Delayed-Release Tablets approved by the U.S. Food and Drug Administration (USFDA).“This launch is a testament to our core strengths in areas of research and development and intellectual property,” says Marc Kikuchi, Chief Executive Officer, North America Generics. “We are excited to be a part of forming the first generic market for Vimovo ® Tablets and to provide an affordable treatment alternative for patients.” The Vimovo ® (Naproxen and Esomeprazole Magnesium) Delayed-Release Tablets brand had U.S. sales of approximately $414 million MAT for the most recent twelve months ending in December 2019 according to IQVIA Health*.Dr. Reddy’s Naproxen and E...
Ahmed (name changed) from Bangladesh a 22-year-old doing his Bachelors in Law was diagnosed with a condition called Avascular necrosis of the right femoral head. A condition which occurs due to poor blood supply to the femoral head. The problem started a year ago, when he had complained that he had unbearable progressive pain in his right hip. The pain which went on for a year not only had affected his daily routine but his athletic career and his education also. Avascular Necrosis commonly affects youngsters and is most often due to bone dislocations, fractures, alcoholism and longstanding usage of steroids for medical conditions. Even though the exact reason for this condition is still not known but the region most commonly affected is the femoral head. As the head of femur progressively get damaged until the head finally collapses leading to severe pain.He was advised a total hip replacement at his hometown but was reluctant due to his age, limitation of his athletic activities and...
Comments
Post a Comment